Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 12, 2017 07:00 ET | Source: ProQR Therapeutics N.V.

ProQR spins out Amylon Therapeutics as a privately-held company focused on central nervous system (CNS) therapeutics

Key updates ProQR spins out CNS-focused company, Amylon Therapeutics, with seed funding from a group of institutional and private investors.As part of the transaction, ProQR has granted an exclusive...